PDL BioPharma, Inc. Accounts Receivable Change

Accounts Receivable Change of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Receivable Change growth rates and interactive chart.


Highlights and Quick Summary

  • Accounts Receivable Change for the quarter ending June 29, 2020 was $1.83 Million (a -246.75% decrease compared to previous quarter)
  • Year-over-year quarterly Accounts Receivable Change decreased by -85.2%
  • Annual Accounts Receivable Change for 2019 was $8.2 Million (a -12.34% decrease from previous year)
  • Annual Accounts Receivable Change for 2018 was $9.35 Million (a -2.7% decrease from previous year)
  • Annual Accounts Receivable Change for 2017 was $9.61 Million (a -123.95% decrease from previous year)
  • Twelve month Accounts Receivable Change ending June 29, 2020 was $12.3 Million (a 124.7% increase compared to previous quarter)
  • Twelve month trailing Accounts Receivable Change increased by 410.32% year-over-year
Trailing Accounts Receivable Change for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$12.3 Million $5.48 Million $8.2 Million $2.41 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Receivable Change of PDL BioPharma, Inc.

Most recent Accounts Receivable Changeof PDLI including historical data for past 10 years.

Interactive Chart of Accounts Receivable Change of PDL BioPharma, Inc.

PDL BioPharma, Inc. Accounts Receivable Change for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $1.83 $-1.25
2019 $-0.62 $12.35 $-5.0 $1.47 $8.2
2018 $-6.4 $4.04 $3.22 $8.49 $9.35
2017 $-13.56 $8.11 $-3.38 $18.44 $9.61
2016 $-8.33 $-28.91 $-2.88 $-40.12
2015 $0.59 $-0.19 $-0.4 $0.3 $0.3
2014 $-11.35
2013 $-0.9 $0.15 $0.22
2012 $-0.37 $0.0 $0.0 $0.6 $0.23
2011 $-0.6 $0.0 $0.15 $0.32 $-0.13
2010 $-0.22 $-0.1 $0.0 $0.58

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.